BIORESTORATIVE THERAPIES INC (BRTX) Stock News

USA - NASDAQ:BRTX - US0906556065 - Common Stock

1.37 USD

-0.03 (-2.14%)

Last: 11/7/2025, 8:00:02 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

BRTX Latest News, Press Relases and Analysis

All

Press Releases

13 days ago - By: Chartmill - Mentions: SOHO ITGR BYND INBX ...

News Image

The trading volume of these stocks is deviating from the norm in today's session.

5 days ago - By: BioRestorative Therapies, Inc

BioRestorative Therapies to Report Third Quarter 2025 Financial Results and Host Conference Call on November 12, 2025

13 days ago - By: Benzinga - Mentions: BMRA SSKN CODX NTRB ...

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

14 days ago - By: BioRestorative Therapies, Inc

BioRestorative Awarded Notice of Allowance for Japanese Patent – Expands Protection for Potential Cell-Based Alternative to Multi-Billion Dollar GLP-1 Drug Market

19 days ago - By: BioRestorative Therapies, Inc

BioRestorative Strengthens Commercial Leadership with Appointment of Crystal Romano as Head of Global Commercial Operations to Accelerate Growth of Cell-Based Product Portfolio

26 days ago - By: BioRestorative Therapies, Inc

BioRestorative Therapies to Participate in the 2025 Maxim Growth Summit

a month ago - By: Zacks Investment Research

Is Bayer (BAYRY) Outperforming Other Medical Stocks This Year?

a month ago - By: BioRestorative Therapies, Inc

BioRestorative CEO Lance Alstodt Interviewed on “The Big Biz Show”

a month ago - By: BioRestorative Therapies, Inc

BioRestorative Therapies Announces $1.085 Million Registered Direct Offering Priced Above Market

3 months ago - By: Zacks Investment Research - Mentions: BDTX

Are Medical Stocks Lagging Black Diamond Therapeutics (BDTX) This Year?

3 months ago - By: Zacks Investment Research

Biorestorative Therapies, Inc. (BRTX) Reports Q2 Loss, Beats Revenue Estimates

3 months ago - By: Benzinga

Earnings Outlook For BioRestorative Therapies

3 months ago - By: Zacks Investment Research - Mentions: ZYME

Zymeworks Inc. (ZYME) Tops Q2 Earnings and Revenue Estimates

3 months ago - By: Zacks Investment Research - Mentions: TRDA

Entrada Therapeutics, Inc. (TRDA) Reports Q2 Loss, Lags Revenue Estimates

3 months ago - By: BioRestorative Therapies, Inc

BioRestorative Therapies to Report Second Quarter 2025 Financial Results and Host Conference Call on August 12, 2025

5 months ago - By: BioRestorative Therapies, Inc

BioRestorative to Participate in Benzinga All-Access Show Today to Discuss Compelling BRTX-100 Clinical Data, Leadership Enhancements and Strategic updates

5 months ago - By: BioRestorative Therapies, Inc

BioRestorative Announces Share Repurchase Program

5 months ago - By: BioRestorative Therapies, Inc

BioRestorative Reports Compelling Preliminary Data for FDA-Fast-Tracked BRTX-100 – an Autologous Stem Cell Therapy to Treat Chronic Lumbar Disc Disease

5 months ago - By: BioRestorative Therapies, Inc

BioRestorative Welcomes Serial Regenerative Medicine Entrepreneur, Company Builder and Leader, Sandy Lipkins, to BRTX Team

5 months ago - By: BioRestorative Therapies, Inc

BioRestorative to Present Major Update on Promising Preliminary Phase 2 BRTX-100 Data at ISSCR 2025

6 months ago - By: Zacks Investment Research - Mentions: CGEN

Biorestorative Therapies, Inc. (BRTX) Reports Q1 Loss, Lags Revenue Estimates

6 months ago - By: Zacks Investment Research - Mentions: STOK

Stoke Therapeutics, Inc. (STOK) Tops Q1 Earnings and Revenue Estimates

6 months ago - By: BioRestorative Therapies, Inc

Phase 2 Trial of BRTX-100 in cLDD Continues to Generate Positive Preliminary Blinded Data

6 months ago - By: Zacks Investment Research - Mentions: CHRS

Coherus BioSciences (CHRS) Reports Q1 Loss, Lags Revenue Estimates

6 months ago - By: BioRestorative Therapies, Inc

BioRestorative Therapies to Report First Quarter 2025 Financial Results and Host Conference Call on May 14, 2025

6 months ago - By: BioRestorative Therapies, Inc

BioRestorative to Present a BRTX-100 Clinical Update at ISCT 2025

7 months ago - By: BioRestorative Therapies, Inc

BioRestorative to Participate in Benzinga All-Access Show Today to Discuss Recent Achievements of Key Clinical & Regulatory Milestones, and Highlight Commercial Opportunities

7 months ago - By: BioRestorative Therapies, Inc

BioRestorative Confirms No Material Impact from Reciprocal Tariffs; All BRTX-100 Production & Manufacturing Performed in the United States